Linear growth in anorexia nervosa

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue SUPPL. 3, 2010, Pages

  Eckhardt, Sarah Marie ^a   Ahmed, S Faisal ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GROWTH HORMONE RELEASING FACTOR; HUMAN GROWTH HORMONE; HYDROCORTISONE; LIOTHYRONINE; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOSTATIN; THYROXINE;

ADOLESCENCE; ANOREXIA NERVOSA; ARTICLE; BONE TURNOVER; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; GROWTH HORMONE RELEASE; GROWTH RETARDATION; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PRIORITY JOURNAL; RISK FACTOR; SHORT STATURE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADOLESCENT; AGE OF ONSET; ANOREXIA NERVOSA; BODY HEIGHT; CHILD; FEMALE; GROWTH; GROWTH DISORDERS; HORMONES; HUMANS; MALE;

EID: 78650489604     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181f83eae     Document Type: Article

References (10)

1. Nicholls D, Stanhope R. Medical complications of anorexia nervosa in children and young adolescents. Eur Eat Disorders Rev 2000;8:170-80.
2. Preti A, Girolamo G, Vilagut G, et al. The epidemiology of eating disorders in six European countries: Results of the ESEMeD-WMH project. J Psychiatr Res 2009;43:1125-32.
3. Pfeiffer RJ, Lucas AR, Ilstrup DM. Effect of anorexia nervosa on linear growth. Clin Pediatr 1986;25:7-12.
4. Favaro A, Tenconi E, Degortes D, et al. Association between low height and eating disorders: Cause or effect? Int J Eat Disord 2007;40:549-53.
5. Nicholls DE, Viner RM. Childhood risk factors for lifetime anorexia nervosa by age 30 years in a national birth cohort. J Am Acad Child Adolesc Psychiatr 2009;48:791-9.
6. Misra M, Klibanski A. Neuroendocrine consequences of anorexia nervosa in adolescents. In: Loche S, Cappa M, Ghizzoni L, et al, eds. Pediatric Neuroendocrinology. Endocr Dev Basel: Karger; 2010;17:197-214.
7. Fisher M, Golden NH, Katzman DK, et al. Eating disorders in adolescents: Abackground paper. J Adol Health 1995;16:420-37.
8. Hashizume K, Suzuki S, Komatsu A, et al. Administration of recombinant human growth hormone normalizes GH-IGF1 axis and improves malnutrition-related disorders in patients with anorexia nervosa. Endocr J 2007;54:319-27.
9. Grinspoon S, Miller K, Herzog D, et al. Effects of recombinant human insulin-line growth factor and oestrogen administration on IGF-1, IGF binding protein-2 and IGFBP-3 in anorexia nervosa. J Clin Endocrinol Metab 2003;88:1142-49.
10. Grinspoon S, Thomas L, Miller K, et al. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002;87: 2883-91.